Global mRNA 2.0 Market - By Technology
Global mRNA 2.0 Market – Infectious Disease Vaccines
Global mRNA 2.0 Market – By End-User
Global mRNA 2.0 Market – By Region
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global mRNA 2.0 Market Snapshot
Chapter 4. Global mRNA 2.0 Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2024)
4.9. Use/impact of AI on mRNA 2.0 Market Industry Trends
4.10. Global mRNA 2.0 Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034
Chapter 5. mRNA 2.0 Market Segmentation 1: By Technology, Estimates & Trend Analysis
5.1. Market Share by Technology, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Technology:
5.2.1. Self-Amplifying mRNA (saRNA)
5.2.2. Optimized Non-amplifying mRNA
5.2.3. Circular RNA (circRNA)
5.2.4. Programmable/Logic-Gated mRNA
Chapter 6. mRNA 2.0 Market Segmentation 2: By Application, Estimates & Trend Analysis
6.1. Market Share by Application, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:
6.2.1. Infectious Disease Vaccines
6.2.2. Oncology
6.2.3. Rare & Genetic Diseases
6.2.4. Autoimmune & Inflammatory Diseases
6.2.5. Cardiovascular & Metabolic
Chapter 7. mRNA 2.0 Market Segmentation 3: By End-User, Estimates & Trend Analysis
7.1. Market Share by End-User, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following End-User:
7.2.1. Hospitals & Clinics
7.2.2. Research Institutions
7.2.3. Biopharmaceutical Companies
Chapter 8. mRNA 2.0 Market Segmentation 5: Regional Estimates & Trend Analysis
8.1. Global mRNA 2.0 Market, Regional Snapshot 2024 & 2034
8.2. North America
8.2.1. North America mRNA 2.0 Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.2.1.1. US
8.2.1.2. Canada
8.2.2. North America mRNA 2.0 Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
8.2.3. North America mRNA 2.0 Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.2.4. North America mRNA 2.0 Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
8.3. Europe
8.3.1. Europe mRNA 2.0 Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.3.1.1. Germany
8.3.1.2. U.K.
8.3.1.3. France
8.3.1.4. Italy
8.3.1.5. Spain
8.3.1.6. Rest of Europe
8.3.2. Europe mRNA 2.0 Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
8.3.3. Europe mRNA 2.0 Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.3.4. Europe mRNA 2.0 Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
8.4. Asia Pacific
8.4.1. Asia Pacific mRNA 2.0 Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.4.1.1. India
8.4.1.2. China
8.4.1.3. Japan
8.4.1.4. Australia
8.4.1.5. South Korea
8.4.1.6. Hong Kong
8.4.1.7. Southeast Asia
8.4.1.8. Rest of Asia Pacific
8.4.2. Asia Pacific mRNA 2.0 Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
8.4.3. Asia Pacific mRNA 2.0 Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.4.4. Asia Pacific mRNA 2.0 Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
8.5. Latin America
8.5.1. Latin America mRNA 2.0 Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.5.1.1. Brazil
8.5.1.2. Mexico
8.5.1.3. Rest of Latin America
8.5.2. Latin America mRNA 2.0 Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
8.5.3. Latin America mRNA 2.0 Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.5.4. Latin America mRNA 2.0 Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
8.6. Middle East & Africa
8.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.6.1.1. GCC Countries
8.6.1.2. Israel
8.6.1.3. South Africa
8.6.1.4. Rest of Middle East and Africa
8.6.2. Middle East & Africa mRNA 2.0 Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
8.6.3. Middle East & Africa mRNA 2.0 Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.6.4. Middle East & Africa mRNA 2.0 Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Moderna
9.2.1.1. Business Overview
9.2.1.2. Key Technology/Service Overview
9.2.1.3. Financial Performance
9.2.1.4. Geographical Presence
9.2.1.5. Recent Developments with Business Strategy
9.2.2. BioNTech
9.2.3. Pfizer
9.2.4. CureVac
9.2.5. Arcturus Therapeutics
9.2.6. GSK
9.2.7. AstraZeneca
9.2.8. Merck
9.2.9. Orna Therapeutics
9.2.10. Strand Therapeutics
9.2.11. ReCode Therapeutics
9.2.12. Abogen Biosciences
9.2.13. Nutcracker Therapeutics
9.2.14. Gritstone Bio
9.2.15. Vertex Pharmaceuticals
9.2.16. Ethris
9.2.17. Ziphius Vaccines
9.2.18. Replicate Bioscience
9.2.19. Laronde (Senda Biosciences)
9.2.20. CircBio
9.2.21. Anima Biotech
9.2.22. HDT Bio
9.2.23. VaxEquity
9.2.24. Voltron Therapeutics
9.2.25. Chimeron Bio
9.2.26. MiNA Therapeutics
9.2.27. Acuitas Therapeutics
9.2.28. Evox Therapeutics
9.2.29. DSP
9.2.30. eTheRNA
9.2.31. Kernal Biologics
9.2.32. CSL
9.2.33. Esphera SynBio
9.2.34. Others
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.